Clinical Trial Update: Antidepressant Effects of NR2B in Major Depression [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the antidepressant effects of an NR2B NMDA receptor antagonist in adults with major depressive disorder; results were posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• NR2B antagonist

Snippet

Sponsor: National Institute of Mental Health (NIMH) | Conditions: Major Depression | Phase 1 | Status: COMPLETED | Results posted: 2011-04-07